Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens
Clinical trial NCT00481689 · COMPLETED
Trial details
- NCT number
- NCT00481689
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.